Target intelligence / Profile preview

ACN9 homolog pseudogene

Molecular classification: Pseudogene, Processed pseudogene, non-processed pseudogene, Other

Overview

The ACN9 homolog pseudogene (ENSG00000223787) is a nonfunctional genomic DNA segment that resembles the protein-coding ACN9 gene. Pseudogenes are typically generated through gene duplication or retrotransposition, resulting in sequences with disablements such as frameshifts, premature stop codons, or truncations that prevent normal gene expression and protein production. This pseudogene does not produce a functional protein and has no recognized biological, therapeutic, or diagnostic role.

Other names: ACN9PACN9 homolog (pseudogene)

Beyond the preview

Go deeper on ACN9 homolog pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ACN9 homolog pseudogene.

Explore the full profile